SG11201705271YA - Fusion protein comprising a ligand binding domain of vegf and pdgf - Google Patents
Fusion protein comprising a ligand binding domain of vegf and pdgfInfo
- Publication number
- SG11201705271YA SG11201705271YA SG11201705271YA SG11201705271YA SG11201705271YA SG 11201705271Y A SG11201705271Y A SG 11201705271YA SG 11201705271Y A SG11201705271Y A SG 11201705271YA SG 11201705271Y A SG11201705271Y A SG 11201705271YA SG 11201705271Y A SG11201705271Y A SG 11201705271YA
- Authority
- SG
- Singapore
- Prior art keywords
- pdgf
- vegf
- fusion protein
- binding domain
- ligand binding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562131261P | 2015-03-11 | 2015-03-11 | |
| PCT/US2016/021762 WO2016145189A1 (en) | 2015-03-11 | 2016-03-10 | Fusion protein comprising a ligand binding domain of vegf and pdgf |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201705271YA true SG11201705271YA (en) | 2017-07-28 |
Family
ID=55642865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201705271YA SG11201705271YA (en) | 2015-03-11 | 2016-03-10 | Fusion protein comprising a ligand binding domain of vegf and pdgf |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11299531B2 (es) |
| EP (1) | EP3268386B1 (es) |
| JP (1) | JP6649393B2 (es) |
| KR (1) | KR20170117107A (es) |
| CN (1) | CN107108757B (es) |
| AU (1) | AU2016229053B2 (es) |
| BR (1) | BR112017014615A2 (es) |
| CA (1) | CA2970384A1 (es) |
| ES (1) | ES2873379T3 (es) |
| MX (1) | MX2017008643A (es) |
| SG (1) | SG11201705271YA (es) |
| TW (1) | TWI675844B (es) |
| WO (1) | WO2016145189A1 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9840553B2 (en) | 2014-06-28 | 2017-12-12 | Kodiak Sciences Inc. | Dual PDGF/VEGF antagonists |
| CN108430489B (zh) | 2015-06-28 | 2022-03-25 | 新源生物科技股份有限公司 | 用于抑制血管新生的融合蛋白 |
| CN108712911A (zh) | 2015-12-30 | 2018-10-26 | 科达制药股份有限公司 | 抗体及其缀合物 |
| CN110248672A (zh) * | 2017-02-06 | 2019-09-17 | 中央研究院 | 重组蛋白及其用途 |
| WO2019096226A1 (en) | 2017-11-16 | 2019-05-23 | Chengdu Easton Biopharmaceuticals Co., Ltd. | Pasylated vegfr/pdgfr fusion proteins and their use in therapy |
| CN111406071B (zh) * | 2017-11-16 | 2024-01-16 | 成都硕德药业有限公司 | Pas化的vegfr/pdgfr融合蛋白及其在治疗中的用途 |
| EP3758735B1 (en) * | 2018-02-28 | 2023-12-13 | AP Biosciences, Inc. | Bifunctional proteins combining checkpoint blockade for targeted therapy |
| TW202021988A (zh) * | 2018-08-17 | 2020-06-16 | 三鈺生物科技股份有限公司 | 抗血管新生融合蛋白及其用途 |
| CN112552410A (zh) * | 2019-09-26 | 2021-03-26 | 三生国健药业（上海）股份有限公司 | 一种抗体融合蛋白及其制法和在抗肿瘤中的应用 |
| US11912784B2 (en) | 2019-10-10 | 2024-02-27 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
| CN112834753A (zh) * | 2019-11-22 | 2021-05-25 | 北京泰德制药股份有限公司 | 一种融合蛋白体外生物学活性的检测方法 |
| US20230137756A1 (en) * | 2020-03-30 | 2023-05-04 | The Wistar Institute Of Anatomy And Biology | Synthetic Soluble Receptor Mimics and Methods of Use for Treatment of COVID-19 |
| CN116836281A (zh) * | 2022-03-25 | 2023-10-03 | 英诺湖医药(杭州)有限公司 | B7h3抗体及包含其的双功能抗体 |
| US11723955B1 (en) * | 2022-05-13 | 2023-08-15 | Allgenesis Biotherapeutics Inc. | VEGFR fusion protein pharmaceutical composition |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003900481A0 (en) * | 2003-02-05 | 2003-02-20 | Queensland University Of Technology | Synthetic modulators of cell migration and growth |
| US20060234347A1 (en) * | 2005-04-13 | 2006-10-19 | Harding Thomas C | Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors |
| CN102311502B (zh) | 2010-07-10 | 2013-12-25 | 成都康弘生物科技有限公司 | 一种抑制血管新生或生长的融合蛋白及其医疗应用 |
| PT2968461T (pt) | 2013-03-13 | 2022-12-26 | Genzyme Corp | Proteínas de fusão que compreendem porções de ligação ao pdgf e ao vegf e seus métodos de utilização |
| CN105026433B (zh) * | 2014-01-24 | 2018-10-19 | 上海恒瑞医药有限公司 | VEGF与PDGFRβ双特异性融合蛋白及其用途 |
| CN108430489B (zh) * | 2015-06-28 | 2022-03-25 | 新源生物科技股份有限公司 | 用于抑制血管新生的融合蛋白 |
-
2016
- 2016-03-10 SG SG11201705271YA patent/SG11201705271YA/en unknown
- 2016-03-10 US US15/542,692 patent/US11299531B2/en active Active
- 2016-03-10 ES ES16713194T patent/ES2873379T3/es active Active
- 2016-03-10 EP EP16713194.5A patent/EP3268386B1/en active Active
- 2016-03-10 CA CA2970384A patent/CA2970384A1/en not_active Abandoned
- 2016-03-10 WO PCT/US2016/021762 patent/WO2016145189A1/en active Application Filing
- 2016-03-10 KR KR1020177024998A patent/KR20170117107A/ko not_active Application Discontinuation
- 2016-03-10 TW TW105107330A patent/TWI675844B/zh active
- 2016-03-10 CN CN201680004514.1A patent/CN107108757B/zh active Active
- 2016-03-10 MX MX2017008643A patent/MX2017008643A/es unknown
- 2016-03-10 BR BR112017014615A patent/BR112017014615A2/pt not_active Application Discontinuation
- 2016-03-10 JP JP2017545668A patent/JP6649393B2/ja active Active
- 2016-03-10 AU AU2016229053A patent/AU2016229053B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2873379T3 (es) | 2021-11-03 |
| CN107108757B (zh) | 2021-10-19 |
| AU2016229053A8 (en) | 2017-09-28 |
| WO2016145189A8 (en) | 2017-09-08 |
| WO2016145189A1 (en) | 2016-09-15 |
| MX2017008643A (es) | 2018-04-26 |
| JP2018512120A (ja) | 2018-05-17 |
| TWI675844B (zh) | 2019-11-01 |
| KR20170117107A (ko) | 2017-10-20 |
| AU2016229053B2 (en) | 2018-07-12 |
| US11299531B2 (en) | 2022-04-12 |
| EP3268386B1 (en) | 2021-03-31 |
| BR112017014615A2 (pt) | 2018-02-06 |
| JP6649393B2 (ja) | 2020-02-19 |
| CN107108757A (zh) | 2017-08-29 |
| AU2016229053A1 (en) | 2017-07-06 |
| US20170369552A1 (en) | 2017-12-28 |
| EP3268386A1 (en) | 2018-01-17 |
| CA2970384A1 (en) | 2016-09-15 |
| TW201643186A (zh) | 2016-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201705271YA (en) | Fusion protein comprising a ligand binding domain of vegf and pdgf | |
| IL266715A (en) | Fusion proteins containing binding sites for pdgf and vegf and methods of using them | |
| IL265489B (en) | Recombinant binding proteins and their uses | |
| IL287291A (en) | A protein that binds to rgma and its use | |
| GB201509062D0 (en) | OX40L fusion proteins and uses thereof | |
| ZA201804601B (en) | Psma binding antibody and uses thereof | |
| PT3099713T (pt) | Proteína quimérica composta por domínio antagonista de ngf e um domínio antagonista de tnfa | |
| HK1258695A1 (zh) | Fmdv和e2的融合蛋白質及其用途 | |
| EP3401330A4 (en) | ANTIBODY-BINDING BINDING BETWEEN VEGF AND NRP1 | |
| ZA201901862B (en) | Modified factor h binding protein | |
| HK1251456A1 (zh) | 免疫球蛋白融合蛋白及其用途 | |
| IL244857A0 (en) | A fusion protein of acetylcholinesterase and the fc region |